Clinical Trial Update: Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating selective depletion of CD45RA+ T cells from allogeneic peripheral blood stem cell grafts to prevent GVHD; study terminated with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CD45RA+ T cell depleted graft

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Graft Versus Host Disease, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2020-08-20